The actual management of pemphigus

G Ital Dermatol Venereol. 2010 Oct;145(5):689-702.

Abstract

Pemphigus is usually treated with systemic prednisone in combination with adjuvant immunosuppressants. Though the mortality associated with pemphigus has been reduced with the use of systemic corticosteroids, the iatrogenic complications have warranted the development of newer therapies. This review discusses the different treatments, therapies and procedures.

Publication types

  • Review

MeSH terms

  • Adrenal Cortex Hormones / therapeutic use
  • Antibodies, Monoclonal / therapeutic use
  • Antibodies, Monoclonal, Murine-Derived / therapeutic use
  • Humans
  • Immunoglobulins, Intravenous / therapeutic use
  • Immunosuppressive Agents / therapeutic use
  • Mycophenolic Acid / analogs & derivatives
  • Mycophenolic Acid / therapeutic use
  • Pemphigus / drug therapy
  • Pemphigus / therapy*
  • Plasma Exchange
  • Plasmapheresis
  • Rituximab

Substances

  • Adrenal Cortex Hormones
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Immunoglobulins, Intravenous
  • Immunosuppressive Agents
  • Rituximab
  • Mycophenolic Acid